Peter Forsyth

I’m grateful to @BN9 for sharing Heather’s incredible story. Heather is a true hero—a courageous warrior whose strength, resilience, and determination inspire us all. Stories like hers are only possible because of groundbreaking discoveries and the generosity of collaborators like Dr. Brian Czerniecki. His scientific leadership, collaboration, and unwavering support continue to move the field forward. Thank you, Brian, for helping make hope a reality for patients and families. @MoffittNews Bay News 9: baynews9.com/fl/tampa/news/…

Hope begins with research—and becomes real through patients. 💙 Heather Curley is living beyond expectations after enrolling in a pioneering dendritic cell vaccine clinical trial for leptomeningeal disease at @MoffittNews. Her story is a powerful reminder of why we never stop pushing for better treatments. Read her inspiring journey: Bay News 9: baynews9.com/fl/tampa/news/… #Glioblastoma #BrainCancer #LeptomeningealDisease #CancerResearch #Immunotherapy #ClinicalTrials #MoffittCancerCenter

It was a pleasure to host Dr. Isabella Glitza, MD, PhD, from MD Anderson Cancer Center last week! We shared ideas about collaborating to improve care for our patients. She is a expert on Melanoma LMD and gave a fantastic talk. We have lots of other to work together on including trial and sharing reagents! Very exciting! We also had a wonderful dinner with Dr. Glitza in a great restaurant. Great time, great food and great friends Photos: Dr. Golnaz Morad and Dr. Glitza, Members of the Department of Neuro-Oncology with Dr. Glitza (center, black attire), followed by a wonderful dinner with colleagues. Clockwise from the lower left corner 8pm: Inna Smalley, PhD, Dr. Isabella "Bella" Glitza, Dr. Jose Guevara, PhD, Dr. Peter Forsyth, and Dr. Yolanda Piña.@MoffittNews #NeuroOncology #Melanoma #LMD #CancerResearch #Collaboration

It was a pleasure to host Dr. Isabella Glitza, MD, PhD, from MD Anderson Cancer Center last week! We shared ideas about collaborating to improve care for our patients. She is a expert on Melanoma LMD and gave a fantastic talk. We have lots of other to work together on including trial and sharing reagents! Very exciting! We also had a wonderful dinner with Dr. Glitza in a great restaurant. Great time, great food and great friends Photos: Members of the Department of Neuro-Oncology with Dr. Glitza (center, black attire), followed by a wonderful dinner with colleagues. Clockwise from the lower left corner 8pm: Inna Smalley, PhD, Dr. Isabella "Bella" Glitza, Dr. Jose Guevara, PhD, Dr. Peter Forsyth, and Dr. Yolanda Piña. @MoffittNews #NeuroOncology #Melanoma #LMD #CancerResearch #Collaboration

During #ASCO26, I spoke with Dr. Patrick Hwu (@PatrickHwuMD ), Moffitt Cancer Center President & CEO about research aimed at improving treatment for brain tumors and melanoma that spreads to the brain. #ASCO26 #MoffittASCO26 @MoffittNews

While at #ASCO26, Peter Forsyth, MD (@PeterForsyth27), stopped by the booth to share research exploring patient-derived tumor models to identify potential treatment strategies for melanoma leptomeningeal disease. #MoffittASCO26

🚨New phase 3 data presented at #ASCO26 compared postoperative stereotactic radiation with cesium-131 tile-based radiation following resection of brain metastases. Moffitt’s Peter Forsyth, MD (@PeterForsyth27), discusses the work by @DrJeffWeinberg of @UTMDAnderson and how tile-based radiation could help redefine postoperative care by improving local control and integrating surgery and radiation into a single treatment approach. #MoffittASCO26

From #ASCO26, Peter Forsyth, MD (@PeterForsyth27), and Brian Czerniecki, MD, PhD (@BCzernieckiMD), discuss the power of cross-disciplinary collaboration in advancing cancer care. Their work combines expertise in neuro-oncology and immunotherapy to develop dendritic cell-based treatments for leptomeningeal disease in patients with breast cancer, with a phase 2 clinical trial now underway. #MoffittASCO26

From #ASCO26, Peter Forsyth, MD (@PeterForsyth27), and Muhammad Jaffer, MD, discuss advances in neuro-oncology, including long-term follow-up from the INDIGO trial showing durable benefits for patients with low-grade glioma and continued momentum toward earlier intervention. They also highlight research focused on understanding and reducing neurologic toxicities associated with cancer therapies, with the goal of preserving quality of life while improving outcomes. #MoffittASCO26

Dendritic Cell Trial Brings Hope for Young Mom With Leptomeningeal Disease | Moffitt @MoffitNews moffitt.org/endeavor/archi…

Pics from March 13.

On March 13 we discussed what we learn from autopsies on patients with leptomeningeal disease (LMD) and how important they are for discovering new and better treatments for this disease. It's an emotional issue, and it's not for everyone-but it's a precious gift that will help us develop cures. I'm going to donate my body to science when my turn comes, but it's a personal decision. We had the first example where we gathered as a group medically and talked about the patient's clinical history. We analyzed what we thought was going on in life, reviewed the radiology studies in detail, and finally the autopsy findings to see what was actually happening in the leptomeningeal. In this case, as we suspected clinically, it wasn't real LMD. So we have refined our diagnostic accuracy. And more to the point, we would not use these tissues to test and discover new targets for effective LMD treatment. A critical critical component in discovering cures for this terrible disease.

We are very grateful to Moffitt for recognizing our success in building (and funding) our LMD Program as one of the Top Research Stories of the year! And very lucky to be in this rich environment of discovery and super enthusiastic collaborations make our transdisciplinary work possible! It’s a magical place for discovery in cancer. Thank you all for the great Team and Dr. Brian Czernicki’s MD PhD. fundamental discoveries in Dendritic Cell Therapies that drive our collaborations. And the other top story is from Dr. Greg Sawyer PhD and his wonderful engineering and imaging center which is unique and world class. We are working now on developing models and new treatments for LMD that are unique and exploiting engineering expertise to understanding this major clinical challenge. It is really, fundamentally an engineering problem so best to get engineers working on it. @MoffittNews

Golfers Vs. Brain Cancer in Oldsmar was an incredible event! @MoffittNews

Great Miles for Moffitt turn out. @MoffittNews

Miles for Moffitt. Go Team Transformers! @MoffittNews